Peter Goettig - Publications

Affiliations: 
University of Salzburg, Salzburg, Salzburg, Austria 

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Goettig P, Brandstetter H, Magdolen V. Surface loops of trypsin-like serine proteases as determinants of function. Biochimie. 166: 52-76. PMID 31505212 DOI: 10.1016/j.biochi.2019.09.004  0.469
2018 Debela M, Magdolen V, Skala W, Elsässer B, Schneider EL, Craik CS, Biniossek ML, Schilling O, Bode W, Brandstetter H, Goettig P. Structural determinants of specificity and regulation of activity in the allosteric loop network of human KLK8/neuropsin. Scientific Reports. 8: 10705. PMID 30013126 DOI: 10.1038/S41598-018-29058-6  0.396
2018 Guo S, Briza P, Magdolen V, Brandstetter H, Goettig P. Activation and activity of glycosylated KLKs 3, 4 and 11. Biological Chemistry. PMID 29975661 DOI: 10.1515/hsz-2018-0148  0.618
2018 Schinagl A, Kerschbaumer RJ, Sabarth N, Douillard P, Scholz P, Voelkel D, Hollerweger JC, Goettig P, Brandstetter H, Scheiflinger F, Thiele M. Role of the Cysteine 81 Residue of Macrophage Migration Inhibitory Factor as a Molecular Redox Switch. Biochemistry. 57: 1523-1532. PMID 29412660 DOI: 10.1021/acs.biochem.7b01156  0.326
2017 Debela M, Magdolen V, Bode W, Brandstetter H, Goettig P. Structural basis for the Zn2+ inhibition of the zymogen-like kallikrein-related peptidase 10. Biological Chemistry. 397: 1251-1264. PMID 27611765 DOI: 10.1515/hsz-2016-0205  0.465
2016 Goettig P. Effects of Glycosylation on the Enzymatic Activity and Mechanisms of Proteases. International Journal of Molecular Sciences. 17. PMID 27898009 DOI: 10.3390/ijms17121969  0.443
2016 Jung S, Fischer J, Spudy B, Kerkow T, Sönnichsen FD, Xue L, Bonvin AM, Goettig P, Magdolen V, Meyer-Hoffert U, Grötzinger J. The solution structure of the kallikrein-related peptidases inhibitor SPINK6. Biochemical and Biophysical Research Communications. PMID 26828269 DOI: 10.1016/J.Bbrc.2016.01.172  0.311
2015 Guo S, Skala W, Magdolen V, Briza P, Biniossek ML, Schilling O, Kellermann J, Brandstetter H, Goettig P. A Single glycan at the 99-loop of human kallikrein-related peptidase 2 regulates activation and enzymatic activity. The Journal of Biological Chemistry. PMID 26582203 DOI: 10.1074/jbc.M115.691097  0.578
2015 Guo S, Skala W, Magdolen V, Brandstetter H, Goettig P. Sweetened kallikrein-related peptidases (KLKs): glycan trees as potential regulators of activation and activity. Biological Chemistry. 395: 959-76. PMID 25153382 DOI: 10.1515/hsz-2014-0140  0.633
2014 Skala W, Utzschneider DT, Magdolen V, Debela M, Guo S, Craik CS, Brandstetter H, Goettig P. Structure-function analyses of human kallikrein-related peptidase 2 establish the 99-loop as master regulator of activity. The Journal of Biological Chemistry. 289: 34267-83. PMID 25326387 DOI: 10.1074/Jbc.M114.598201  0.622
2010 Goettig P, Magdolen V, Brandstetter H. Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs). Biochimie. 92: 1546-67. PMID 20615447 DOI: 10.1016/j.biochi.2010.06.022  0.348
2010 Seiz L, Kotzsch M, Grebenchtchikov NI, Geurts-Moespot AJ, Fuessel S, Goettig P, Gkazepis A, Wirth MP, Schmitt M, Lossnitzer A, Sweep FC, Magdolen V. Polyclonal antibodies against kallikrein-related peptidase 4 (KLK4): immunohistochemical assessment of KLK4 expression in healthy tissues and prostate cancer. Biological Chemistry. 391: 391-401. PMID 20180634 DOI: 10.1515/BC.2010.033  0.399
2009 Yoon H, Blaber SI, Debela M, Goettig P, Scarisbrick IA, Blaber M. A completed KLK activome profile: investigation of activation profiles of KLK9, 10, and 15. Biological Chemistry. 390: 373-7. PMID 19090718 DOI: 10.1515/Bc.2009.026  0.43
2008 Debela M, Beaufort N, Magdolen V, Schechter NM, Craik CS, Schmitt M, Bode W, Goettig P. Structures and specificity of the human kallikrein-related peptidases KLK 4, 5, 6, and 7. Biological Chemistry. 389: 623-32. PMID 18627343 DOI: 10.1515/Bc.2008.075  0.384
2007 Debela M, Hess P, Magdolen V, Schechter NM, Steiner T, Huber R, Bode W, Goettig P. Chymotryptic specificity determinants in the 1.0 A structure of the zinc-inhibited human tissue kallikrein 7. Proceedings of the National Academy of Sciences of the United States of America. 104: 16086-91. PMID 17909180 DOI: 10.1073/Pnas.0707811104  0.369
2007 Debela M, Goettig P, Magdolen V, Huber R, Schechter NM, Bode W. Structural Basis of the Zinc Inhibition of Human Tissue Kallikrein 5 Journal of Molecular Biology. 373: 1017-1031. PMID 17881000 DOI: 10.1016/J.Jmb.2007.08.042  0.305
2006 Debela M, Magdolen V, Grimminger V, Sommerhoff C, Messerschmidt A, Huber R, Friedrich R, Bode W, Goettig P. Crystal structures of human tissue kallikrein 4: activity modulation by a specific zinc binding site. Journal of Molecular Biology. 362: 1094-107. PMID 16950394 DOI: 10.1016/J.Jmb.2006.08.003  0.605
2006 Debela M, Magdolen V, Schechter N, Valachova M, Lottspeich F, Craik CS, Choe Y, Bode W, Goettig P. Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences. The Journal of Biological Chemistry. 281: 25678-88. PMID 16740631 DOI: 10.1074/Jbc.M602372200  0.422
2002 Goettig P, Groll M, Kim JS, Huber R, Brandstetter H. Structures of the tricorn-interacting aminopeptidase F1 with different ligands explain its catalytic mechanism. The Embo Journal. 21: 5343-52. PMID 12374735 DOI: 10.1093/Emboj/Cdf552  0.31
Show low-probability matches.